Loading organizations...
§ Private Profile · Espoo, Finland
Mycoprotein ingredient producer creating PEKILO® via fungal fermentation of side streams for human food, pet food, and aquafeed.
Enifer is an Espoo, Finland-based biotechnology company that produces a sustainable mycoprotein ingredient called PEKILO through the continuous fungal fermentation of various industrial side streams. The organization manufactures this high-protein powder as a food-grade alternative to traditional plant and animal proteins for commercial use across the human food, pet food, and aquafeed industries. Enifer has secured €50 million in total financing to date, which includes a recent €24 million funding package featuring a €12 million European Union grant to develop a €33 million commercial-scale manufacturing facility. The business is backed by venture capital investors such as Nordic FoodTech VC and Voima Ventures, and it has established strategic partnerships with major corporate customers including Skretting, Purina, and Valio. Enifer was founded in 2020 by former VTT research scientists Simo Ellilä, Anssi Rantasalo, Heikki Keskitalo, Joosu Kuivanen, and Ville Pihlajaniemi.
Enifer has raised $81.3M across 5 funding rounds.
Enifer has raised $81.3M in total across 5 funding rounds.
Enifer has raised $81.3M across 5 funding rounds. Most recently, it raised $39.1M Debt / Grant / Series B in May 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 22, 2024 | $39.1M Debt Financing | Tero Saarno | Toni Mikkonen, Finnvera, Nordic Foodtech VC, Valio, Voima Ventures | Announced |
| May 1, 2024 | $16M Series B | — | Nordic Foodtech VC, Voima Ventures | Announced |
| Jan 10, 2024 | $13.1M Grant | — | — | Announced |
| Apr 19, 2023 | $12.1M Series A | Lissy Smit | Nordic Foodtech VC, JAN Patrick Haikkola, Tuomas Salusjärvi, Voima Ventures | Announced |
| Oct 1, 2020 | $1M Seed | — | Nordic Foodtech VC, Voima Ventures | Announced |
Enifer has raised $81.3M in total across 5 funding rounds.
Enifer's investors include Tero Saarno, Toni Mikkonen, Finnvera, Nordic Foodtech VC, Valio, Voima Ventures, Nordic FoodTech VC, Lissy Smit, Jan-Patrick Haikkola, Tuomas Salusjärvi.
Enifer is a Finnish biotech company specializing in sustainable protein production through fungal fermentation. It develops and commercializes PEKILO® mycoprotein, a fungi-based protein ingredient derived from circular economy by-products, serving the aquafeed, pet food, and food production industries. PEKILO® offers a nutritious, neutral-tasting, and environmentally friendly alternative to traditional animal and plant proteins, with a low water and land footprint. Enifer has demonstrated strong growth momentum, securing over $53 million in funding and partnerships with global industry leaders like Skretting, Purina, and Valio[1][2][3][4].
Founded in 2020 as a spin-off from the VTT Technical Research Centre of Finland, Enifer was established by five scientists who aimed to advance and commercialize the proprietary PEKILO® technology. This technology, originally developed and used by the Finnish forest industry since the 1970s, enables the biotechnological conversion of dilute industrial side streams into high-protein fungal biomass. Enifer has modernized and optimized this process using contemporary biotechnology to address global protein demand sustainably[1][2][6].
Enifer rides the global trend toward sustainable and alternative protein sources driven by environmental concerns, resource scarcity, and consumer demand for ethical food production. The timing is critical as the food industry seeks scalable, low-impact protein solutions to replace or supplement animal and plant proteins. Enifer’s circular economy approach aligns with increasing regulatory and market pressures to reduce waste and carbon emissions. By enabling the use of industrial by-products, Enifer contributes to a more sustainable food ecosystem and influences the broader adoption of biotechnology in food production[1][2][3][4].
Enifer is poised for significant growth with its new production facility in Kantvik, Finland, expected to produce 3,000 tons of mycoprotein annually starting in 2025. Future trends shaping its journey include rising demand for sustainable proteins, regulatory approvals such as Novel Food status, and expanding applications in various food sectors. As Enifer scales, its influence may extend beyond protein supply to shaping circular bioeconomy practices and fostering innovation in fungal biotechnology. The company’s legacy technology combined with modern biotech advances positions it well to feed a growing global population sustainably[4].